Cardiac troponin I in congenital heart defects with pressure or volume overload

References

• Kanaan UB, Chiang VW. Cardiac troponins in pediatrics. Pediatr Emerg Care. 2004;20:323–9.
   PubMed Web of Science ®Google Scholar
• Patil H, Vaidya O, Bogart D. A review of causes and systemic approach to cardiac troponin elevation. Clin Cardiol. 2011;34:723–8.
   PubMed Web of Science ®Google Scholar
• Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O’Connor CM, Felker GM. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol. 2010;56:1071–8.
   PubMed Web of Science ®Google Scholar
• Missov E, Mair J. A novel biochemical approach to congestive heart failure: cardiac troponin T. Am Heart J. 1999; 138:95–9.
   PubMed Web of Science ®Google Scholar
• Cea LB. Natriuretic peptide family: new aspects. Curr Med Chem Cardiovasc Hematol Agents. 2005;3:87–98.
   PubMedGoogle Scholar
• Nir A, Bar-Oz B, Perles Z, Brooks R, Korach A, Rein AJ. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr. 2004;93:603–7.
   PubMed Web of Science ®Google Scholar
• Kubo T, Kitaoka H, Okawa M, Yamanaka S, Hirota T, Hoshikawa E, et al. Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy. Clinical Cardiology. 2010;33:E1–7.
   PubMedGoogle Scholar
• Bottio T, Vida V, Padalino M, Gerosa G, Stellin G. Early and long-term prognostic value of Troponin-I after cardiac surgery in newborns and children. Eur J Cardiothorac Surg. 2006;30:250–5.
   PubMed Web of Science ®Google Scholar
• Modi P, Imura H, Angelini GD, Pawade A, Parry AJ, Suleiman MS, Caputo M. Pathology-related troponin I release and clinical outcome after pediatric open heart surgery. J Cardiac Surg. 2003;18:295–300.
   PubMed Web of Science ®Google Scholar
• Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK, et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr. 2010;23:465–95.
   PubMed Web of Science ®Google Scholar
• Eriksson S, Ilva T, Becker C, Lund J, Porela P, Pulkki K, et al. Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies. Clin Chem. 2005;51:848–55.
   PubMed Web of Science ®Google Scholar
• Tang G, Wu Y, Zhao W, Shen Q. Multiple immunoassay systems are negatively interfered by circulating cardiac troponin I autoantibodies. Clin Exp Med. 2012;12:47–53.
   PubMed Web of Science ®Google Scholar
• Eriksson S, Halenius H, Pulkki K, Hellman J, Pettersson K. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem. 2005;51: 839–47.
   PubMed Web of Science ®Google Scholar
• Trevisanuto D, Lachin M, Zaninotto M, Pellegrino PA, Plebani M, Cantarutti F, Zanardo V. Cardiac troponin T in newborn infants with transient myocardial ischemia. Biology Neonate. 1998;73:161–5.
   PubMedGoogle Scholar
• Bader D, Kugelman A, Lanir A, Tamir A, Mula E, Riskin A. Cardiac troponin I serum concentrations in newborns: a study and review of the literature. Clin Chim Acta. 2006;371:61–5.
   PubMed Web of Science ®Google Scholar
• Almeida CM, Carrapato MR, Pinto F, Pinto M, Ferreira S, Schmitt D, et al. Biochemical markers of neonatal myocardial dysfunction. J Matern Fetal Neonatal Med. 2011;24: 568–73.
   PubMed Web of Science ®Google Scholar
• Pees C, Haas NA, von der Beek J, Ewert P, Berger F, Lange PE. Cardiac troponin I is increased after interventional closure of atrial septal defects. Catheter Cardiovasc Interv. 2003;58:124–9.
   PubMed Web of Science ®Google Scholar
• Tarnok A, Bocsi J, Osmancik P, Hausler HJ, Schneider P, Dahnert I. Cardiac troponin I release after transcatheter atrial septal defect closure depends on occluder size but not on patient's age. Heart. 2005;91:219–22.
   PubMed Web of Science ®Google Scholar
• Kannankeril PJ, Pahl E, Wax DF. Usefulness of troponin I as a marker of myocardial injury after pediatric cardiac catheterization. Am J Cardiol. 2002;90:1128–32.
   PubMed Web of Science ®Google Scholar
• Kupari M, Eriksson S, Turto H, Lommi J, Pettersson K. Leakage of cardiac troponin I in aortic valve stenosis. J Intern Med. 2005;258:231–7.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Ota K, Kajihama A, Nakau K, Manabe H, Kajino H. Volume overload and pressure overload due to left-to-right shunt-induced myocardial injury. - Evaluation using a highly sensitive cardiac Troponin-I assay in children with congenital heart disease. Circ J. 2011;75:2213–9.
   PubMed Web of Science ®Google Scholar
• Masson S, Latini R, Anand IS. An update on cardiac troponins as circulating biomarkers in heart failure. Curr Heart Fail Rep. 2010;7:15–21.
   PubMedGoogle Scholar
• Quivers ES, Murthy JN, Soldin SJ. The effect of gestational age, birth weight, and disease on troponin I and creatine kinase MB in the first year of life. Clin Biochem. 1999;32: 419–21.
   PubMed Web of Science ®Google Scholar
• La’ulu SL, Roberts WL. Performance characteristics of five cardiac Troponin I assays. Clin Chim Acta. 2010;411: 1095–101.
   PubMed Web of Science ®Google Scholar
• Adamczyk M, Brashear RJ, Mattingly PG. Circulating cardiac troponin-I autoantibodies in human plasma and serum. Ann N Y Acad Sci. 2009;1173:67–74.
   PubMed Web of Science ®Google Scholar
• Shmilovich H, Danon A, Binah O, Roth A, Chen G, Wexler D, et al. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. International journal of cardiology 2007;117:198–203.
   PubMed Web of Science ®Google Scholar